Understanding the intricate chemical nature of pharmaceutical intermediates is fundamental to advancing drug development. 7,8-Dimethoxy-3-(3-iodopropyl)-1,3-dihydro-2H-3-benzazepin-2-one (CAS: 148870-57-9) stands out as a molecule of significant interest due to its indispensable role in the synthesis of Ivabradine, a vital medication for cardiac conditions. This compound, a derivative of benzazepinone, is characterized by its specific functional groups – the dimethoxy substituents and the iodopropyl chain – which are critical for its reactivity and utility in subsequent synthetic steps.

The chemical properties of 7,8-Dimethoxy-3-(3-iodopropyl)-1,3-dihydro-2H-3-benzazepin-2-one, such as its density of 1.513 g/cm³, a high boiling point of 504.5ºC, and a flash point of 258.9ºC, highlight its robust nature and suitability for industrial chemical processes. As a 'high purity benzazepinone derivative', its purity level of ≥98.0% ensures that it can be effectively integrated into multi-step drug synthesis without introducing unwanted impurities. The presence of the iodine atom, a good leaving group, makes this compound particularly susceptible to nucleophilic substitution reactions, a common strategy in organic synthesis for introducing new functional groups or extending carbon chains.

NINGBO INNO PHARMCHEM CO.,LTD. specializes in precisely this type of complex organic synthesis. Our expertise in handling challenging reactions allows us to produce this intermediate with the high quality demanded by the pharmaceutical industry. Whether you are researching novel pathways or scaling up existing drug production, our capabilities as a 'pharmaceutical intermediate supplier China' ensure a reliable source for your needs. We are committed to supporting innovation by providing the essential chemical building blocks, such as this key Ivabradine intermediate, that drive progress in modern medicine. Engaging with NINGBO INNO PHARMCHEM CO.,LTD. means partnering with a company that understands the critical balance between chemical precision and therapeutic efficacy.